Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Settings
Settings
Dynamic quotes
OFFON

school135perm Homepage > News > Sectors > Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
02:30pALKERMES PLC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alkermes plc of Class Action Lawsuit and Upcoming Deadline - ALKS
02:22pEKSO BIONICS HOLDINGS INC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline - EKSO
02:21pARRAY BIOPHARMA INC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Array Biopharma Inc. of Class Action Lawsuit and Upcoming Deadline - ARRY
02:20pACORDA THERAPEUTICS INC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acorda Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - ACOR
02:19pENDO INTERNATIONAL PLC : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP
01:22pROYAL PHILIPS : Andover officials vow to not to 'squander' next 2 years
10:52aGLAXOSMITHKLINE : Brian Berridge Tapped to Manage National Toxicology Program
10:46aCANNIMED THERAPEUTICS : files $725M lawsuit against Aurora, others over takeover bid
09:12aRESMED : CPAP Store USA Opens 5 New Retail Stores Across the Country and 45 Additional Stores Available For Franchising
08:48aLAWSUIT : Former Joliet caregiver abused, discriminated for being a lesbian
06:08aASTRAZENECA : FDA OKs first drug for breast cancer patients with gene flaw
04:52aMEDTRONIC : Boston Scientific, Medtronic tout trial data supporting use of neuromodulation devices
03:36aMERIDIAN BIOSCIENCE : Glancy Prongay & Murray Reminds Investors of the January 16, 2018 Deadline in the Class Action Lawsuit Against Meridian Bioscience, Inc. (VIVO)
03:25aAbattis Announces Presence at 2018 Lift Cannabis Expo and Provides Corporate Updates
03:20aABATTIS BIOCEUTICALS : Announces Presence at 2018 Lift Cannabis Expo and Provides Corporate Updates
01/13ZECOTEK PHOTONICS : Increases Non-Brokered Private Placement
01/12TESARO : Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
01/12TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
01/12PEAK PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
01/12MEDICAL FACILITIES CORPORATION : forms joint venture with NueHealth, acquires seven ambulatory surgical centers
01/12SYROS PHARMACEUTICALS, INC. : Other Events (form 8-K)
01/12ONCOSEC MEDICAL INC : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
01/12LIPOCINE INC : LIPOCINE Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Lipocine, Inc. To Contact The Firm
01/12ARADIGM CORPORATION : ARADIGM Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Aradigm Corporation To Contact The Firm
01/12MERIDIAN BIOSCIENCE, INC. : UPCOMING DEADLINE: The Klein Law Firm Reminds Investors of a Class Action on Behalf of Meridian Bioscience, Inc. Shareholders and a Lead Plaintiff Deadline of January 16, 2018 (VIVO)
01/12CATALENT, INC. : Change in Directors or Principal Officers (form 8-K)
01/12CORVEL CORP : Results of Operations and Financial Condition, Other Events (form 8-K)
01/12HEMISPHERX BIOPHARMA INC : Entry into a Material Definitive Agreement (form 8-K)
01/12OVASCIENCE INC : Pomerantz Law Firm Investigates Claims On Behalf of Investors of OvaScience, Inc. - OVAS
01/12EDITAS MEDICINE, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
01/12HALOZYME THERAPEUTICS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
01/12TIVITY HEALTH : Rosen Law Firm Reminds Tivity Health, Inc. Investors of Important January 19 Deadline in Class Action - TVTY
01/12TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 (EN - NL)
01/12Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/12TIGENIX : Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
01/12MERIDIAN BIOSCIENCE, INC. : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Meridian Bioscience, Inc. - VIVO
01/12FLEX PHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
01/12BOSTON SCIENTIFIC : FDA-Approved Spectra WaveWriter SCS System Delivers Multiple Therapies
01/12EKSO LOSS ALERT : Rosen Law Firm Reminds Ekso Bionics Holdings, Inc. Investors of Important Deadline in First Filed Class Action – EKSO
01/12Supernus Mourns the Loss of Board Member William Nuerge
01/12Respiratory Syncytial Virus Infections– Unmet Needs in Adult Targeted Drugs
01/12Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Aradigm Corporation -- ARDM
01/12OLYMPUS : Federal Contracts Awarded to Companies in Washington (Jan. 12)
01/12CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
01/12CHEMED : To Report Fourth-Quarter 2017 Earnings February 14, Related Conference Call To Be Held On February 15
01/12ASTRAZENECA : US OKs 1st drug aimed at women with inherited breast cancer
01/12Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Aradigm Corporation
01/12ASTRAZENECA : LYNPARZA® (olaparib) Approved by US FDA in Germline BRCA-Mutated Metastatic Breast Cancer
01/12MERCK AND : U.S. FDA Approves LYNPARZA® (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer
01/12ASTRAZENECA : Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
01/12VEXIM : +17% Growth in Sales in 2017 up to €21.6 Million
01/12IBA SA : Transparency notification
01/12VALENS GROWORKS : Receives $602,200 from Warrant Exercise
01/12WORLDWIDE HEALTHCARE TRUST : Issue of Equity
01/12GENFIT : Half-year report of liquidity contract with cic
01/12ION BEAM APPLICATIONS : IBA – TRANSPARENCY NOTIFICATION
01/12MYRIAD GENETICS : Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza™ (olaparib) In Patients with Metastatic Breast Cancer
01/12ASTRAZENECA : FDA approves Lynparza for metastatic breast cancer
01/12APOLLO HOSPITALS : submits treatment record of Jayalalithaa to inquiry commission
01/12IFOS CERTIFICATION : Gold Standard Omega-3 Labeling
1 2 3 4 5 6 7 8 9 10Next
Advertisement
Copyright © 2018 Surperformance. All rights reserved.